Maria Cotelli
Overview
Explore the profile of Maria Cotelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
2780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carrarini C, Caraglia N, Quaranta D, Vecchio F, Miraglia F, Giuffre G, et al.
Eur J Neurol
. 2025 Feb;
32(2):e16591.
PMID: 39895250
Background: The Italian Interceptor project is aimed at identifying a prodromal dementia phase and developing a nationwide organizational model. This study compares the sociodemographic and neuropsychological characteristics of mild cognitive...
2.
Catania M, Battipaglia C, Perego A, Salvi E, Maderna E, Cazzaniga F, et al.
Fluids Barriers CNS
. 2025 Jan;
22(1):9.
PMID: 39838411
Background: The approval of new disease-modifying therapies by the U.S. Food and Drug Administration and the European Medicine Agency makes it necessary to optimize non-invasive and cost-effective tools for the...
3.
Benussi A, Cantoni V, Rivolta J, Zoppi N, Cotelli M, Bianchi M, et al.
Mov Disord
. 2024 Aug;
39(11):1993-2003.
PMID: 39136447
Background: Dementia with Lewy bodies (DLB) is characterized by a marked shift of electroencephalographic (EEG) power and dominant rhythm, from the α toward the θ frequency range. Transcranial alternate current...
4.
Lombardo F, Lorenzini P, Mayer F, Massari M, Piscopo P, Bacigalupo I, et al.
Diagn Progn Res
. 2024 Jul;
8(1):11.
PMID: 39049042
Background: In recent years, significant efforts have been directed towards the research and development of disease-modifying therapies for dementia. These drugs focus on prodromal (mild cognitive impairment, MCI) and/or early...
5.
Pappalettera C, Carrarini C, Cappa S, Caraglia N, Cotelli M, Marra C, et al.
Nat Med
. 2024 Jul;
30(11):3094-3095.
PMID: 39025966
No abstract available.
6.
Manenti R, Baglio F, Pagnoni I, Gobbi E, Campana E, Alaimo C, et al.
Front Aging Neurosci
. 2024 Jul;
16:1414593.
PMID: 38966802
Background: In recent years, an increasing number of studies have examined the potential efficacy of cognitive training procedures in individuals with normal ageing and mild cognitive impairment (MCI). Objective: The...
7.
Conca F, Esposito V, Catricala E, Manenti R, LAbbate F, Quaranta D, et al.
Alzheimers Res Ther
. 2024 May;
16(1):98.
PMID: 38704608
Background: The identification and staging of Alzheimer's Disease (AD) represent a challenge, especially in the prodromal stage of Mild Cognitive Impairment (MCI), when cognitive changes can be subtle. Worldwide efforts...
8.
Sandrini M, Manenti R, Gobbi E, Pagnoni I, Geviti A, Alaimo C, et al.
Sci Rep
. 2024 Feb;
14(1):4879.
PMID: 38418583
Episodic memory shows the largest degree of age-related decline. Anodal transcranial Direct Current Stimulation (tDCS) can enhance episodic memory in aging but there is also evidence of response variability even...
9.
Cotelli M, Baglio F, Manenti R, Blasi V, Galimberti D, Gobbi E, et al.
Brain Sci
. 2023 Jul;
13(7).
PMID: 37508992
Primary Progressive Aphasia (PPA) is a syndrome due to different neurodegenerative disorders selectively disrupting language functions. PPA specialist care is underdeveloped. There are very few specialists (neurologists, psychiatrists, neuropsychologists, and...
10.
Conca F, Esposito V, Rundo F, Quaranta D, Muscio C, Manenti R, et al.
Alzheimers Res Ther
. 2023 Jun;
15(1):104.
PMID: 37277846
No abstract available.